CH Biotech R&D Co., Ltd. (TPE:6534)

Market Cap	10.24B +19.6%
Revenue (ttm)	1.82B +11.2%
Net Income	464.00M -2.6%
EPS	4.50 -2.4%
Shares Out	102.80M
PE Ratio	22.13
Forward PE	n/a
Dividend	4.80 (4.82%)
Ex-Dividend Date	Mar 26, 2026

Volume	29,693
Average Volume	324,105
Open	98.80
Previous Close	99.60
Day's Range	97.30 - 99.40
52-Week Range	74.50 - 123.50
Beta	0.10
RSI	60.39
Earnings Date	May 6, 2026

About CH Biotech R&D

CH Biotech R&D Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of agriculture chemicals in Taiwan, the United States, and internationally. It offers fertilizers, biostimulants, and plant growth regulators; and provides biotechnology services. The company was incorporated in 2013 and is headquartered in Nantou City, Taiwan.

• Industry: Agricultural Inputs
• Sector: Materials
• Founded: 2013
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 6534

Financial Performance

In 2025, CH Biotech R&D's revenue was 1.82 billion, an increase of 11.21% compared to the previous year's 1.64 billion. Earnings were 464.00 million, a decrease of -2.60%.